Loading
MB
Microbix Biosystems Inc. Stock: price and insider trades · Canada
Microbix Biosystems Inc.: what insiders have been doing
Every trade that managers of Microbix Biosystems Inc. disclose to SEDI is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 18 October 2026, 29 filings were filed, from 4 insiders.
Not one open-market sale was filed. On the buying side, 3 insiders reported 19 purchases totalling €49k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 3 senior executives. One trade stands out by size: a purchase of €20k from Marino, Martin, disclosed on 28 May 2026.
The latest purchase dates back some time: it was published 37 days ago, on 10 September 2026. Typically, a trade is published a median of 4 days after it takes place. That lag is the time during which only the insider knows about the trade.
For context, the typical company on the same exchange (median of 2,121 companies) published 11 filings over the same period, against 29 filings here. Since 2026, the database holds 19 purchases and no sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
29
Thresholds
n/a
Buy Volume
€48,829
19 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleDaniel Oliveira Costa11 buys
Cameron Lionel Groome5 buys
Martin Marino3 buys
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
CA$0.30
Last declaration on 7 October 2026
Declarations29 total
300,000 shares@ CA$0.3022.7% of flowCommon SharesTSXSEDI:4788848
252,500 sharesCommon SharesTSXSEDI:4788847
252,500 shares@ CA$0.3024.8% of flowCommon SharesTSXSEDI:4788846
279,500 sharesCommon SharesTSXSEDI:4788844
29,500 shares@ CA$0.29565.9% of flowCommon SharesTSXSEDI:4776010
Canonical exit: 9 Dec 2026 (T+90)
279,500 shares@ CA$0.3137.6% of flowCommon SharesTSXSEDI:4762236
280,000 sharesCommon SharesTSXSEDI:4762233
500 shares@ CA$0.2951.1% of flowCommon SharesTSXSEDI:4755945
Canonical exit: 21 Oct 2026 (T+90)
280,000 shares@ CA$0.2935.0% of flowCommon SharesTSXSEDI:4748677
252,500 sharesCommon SharesTSXSEDI:4748676
12,000 shares@ CA$0.29526.5% of flowCommon SharesTSXSEDI:4742059
Canonical exit: 28 Sept 2026 (T+90)
5,000 shares@ CA$0.27514.6% of flowCommon SharesTSXSEDI:4737550
Canonical exit: 13 Sept 2026 (T+90)
2,000 shares@ CA$0.2954.4% of flowCommon SharesTSXSEDI:4737107
Canonical exit: 15 Sept 2026 (T+90)
1,000 shares@ CA$0.2752.1% of flowCommon SharesTSXSEDI:4737106
Canonical exit: 13 Sept 2026 (T+90)
6,000 shares@ CA$0.28518.2% of flowCommon SharesTSXSEDI:4732877
Canonical exit: 8 Sept 2026 (T+90)
1,000 shares@ CA$0.272.9% of flowCommon SharesTSXSEDI:4732875
Canonical exit: 6 Sept 2026 (T+90)
1,000 shares@ CA$0.272.9% of flowCommon SharesTSXSEDI:4732873
Canonical exit: 3 Sept 2026 (T+90)
3,500 shares@ CA$0.2659.9% of flowCommon SharesTSXSEDI:4729934
Canonical exit: 2 Sept 2026 (T+90)
1,500 shares@ CA$0.2654.2% of flowCommon SharesTSXSEDI:4729933
Canonical exit: 1 Sept 2026 (T+90)
4,500 shares@ CA$0.26512.7% of flowCommon SharesTSXSEDI:4729932
Canonical exit: 31 Aug 2026 (T+90)
4,000 shares@ CA$0.2711.5% of flowCommon SharesTSXSEDI:4729931
Canonical exit: 31 Aug 2026 (T+90)
252,500 shares@ CA$0.2527.4% of flowCommon SharesTSXSEDI:4728959
263,500 sharesCommon SharesTSXSEDI:4728950
2,500 shares@ CA$0.2657.1% of flowCommon SharesTSXSEDI:4727076
Canonical exit: 27 Aug 2026 (T+90)
115,000 shares@ CA$0.27556.5% of flowCommon SharesTSXSEDI:4724986
Canonical exit: 26 Aug 2026 (T+90)
25 of 29 declarations
About Microbix Biosystems Inc.
Microbix Biosystems Inc. is a Canadian company focused on developing biological products for diagnostics and research. It specializes in producing reagents and controls for in vitro diagnostic testing.
